Shield Therapeutics PLC (LSE:STX) - Overview

Stock Report

Shield Therapeutics PLC STX

Last Price
GBX173.00

Day Change
0.00|0.00%

As of 06/12/2016
14:23:20 GMT | GBX
Minimum 15 Minutes Delay.

Last Close173.00p
Day Range171.00 - 171.00
Mkt Cap187.10Mil
52-Wk Range147.00 - 190.00
Yield %0.00
ISINGB00BYV81293
Volume1,000
P/E-7.86
P/SInfinity
P/CF-44.73

Share Price

Total Returns 07/12/2016

 Chg (%)  
More ...
Shield Therapeutics PLC-0.57 
FTSE 100 TR GBP1.82
 
Financials
201320142015
More ...
Income Statement
Turnover-0.000.00
Operating Profit--3.39-6.43
Net Profit--13.43-24.49
Reported EPS--12.00-22.00
Balance Sheet
Current Assets-0.562.33
Non Current Assets-0.450.53
Total Assets-1.002.86
Current Liabilities-9.003.58
Total Liabilities-19.2921.50
Total Equity--18.28-18.64
Cash Flow
Operating Cash Flow--3.34-4.18
Net Change in Cash--1.070.25
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-15.40-14.68--11.79---
2017-19.00-16.10--10.75---

Company Profile

Shield Therapeutics PLC operates as a specialty pharmaceutical company specialising in the development and commercialisation of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

702 of 1865 Companies

Index

Outlook

(20/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-10.8113.1215.86
Div Yld (E)0.004.254.26
PEG (E)0.000.200.15
ROCE118.09209.39-30.49
Op Mrgn0.00-16.09-33.54
EPS Grwth0.0010.0923.13
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Andrew Heath
Chief Executive OfficerMr. Carl Sterritt
Chief Financial Officer & Company SecretMr. Richard Jones
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.